The liver is largely composed of hepatocytes and bile duct epithelial cells (BECs). Controversy exists as to whether a liver stem/progenitor cell capable of renewing both hepatocytes and BECs exists. Single cell RNA sequencing of freshly isolated human foetal and healthy adult liver identified hepatocyte, hepatoblast and liver progenitor cell (hLPC) populations. hLPCs, found at the interface between hepatocytes and bile ducts in both foetal and adult tissue, were distinguishable from BECs by their negative expression of TROP-2. Prospective isolation followed by in vitro culture demonstrated their potential for expansion and bi-lineage differentiation. The hLPC expression signature was also conserved within expanded cell populations specific to certain cases of liver injury and cancer. These data support the idea of a true progenitor existing within healthy adult liver that can be activated upon injury. Further work to define the mechanisms regulating hLPC behaviour could advance understanding of human development and disease.
.
Introduction
The liver has a remarkable capacity to regenerate. Conflicting evidence exists regarding the cellular origin of this process and mechanisms at play. Contradictory findings may in part be attributed to differences between regeneration seen at times of normal homeostasis versus times of injury. In rodent models for example the regenerative potential has been attributed to hepatocytes (Yanger et al., 2014 , Schaub et al., 2014 , cholangiocytes (Tarlow et al., 2014) , stem/progenitor cells located in the ductal region (Lu et al., 2015 , Raven et al., 2017 , Petersen et al., 1998 , Huch et al., 2013 , Furuyama et al., 2011 (Dabeva et al., 2000) (Yovchev et al., 2008) , as well as stem/progenitor cells located around the central vein (Wang et al., 2015) . In humans it has been proposed that hLPCs derived from EpCAM + cells found in the ductal plate during foetal liver development, localise to the canals of Hering after birth (Schmelzer et al., 2007) and become reactivated at times of severe chronic liver injury forming what is pathologically described as ductular reactions (Lowes et al., 1999) . Recently it was proposed that EpCAM + liver cells, like stem cells in other adult tissues, are LGR5 + WNT responsive cells that can be isolated from human adult liver, serially expanded ex vivo and still retain their potential for differentiation (Huch et al., 2013) . Given that EpCAM is a cell surface marker likely common to multiple cell types we hypothesized that previously labelled EpCAM + hLPC
represented a heterogeneous population of cells. Single cell RNA sequencing (scRNA-seq) is an unbiased tool to characterise the transcriptome of a single cell which has already been used to uncover the presence and function of novel cell types, and the existence of transient cell states, within previously undefined heterogeneous populations (Treutlein et al., 2014 , Darmanis et al., 2017 , Philippeos et al., 2018 , Proserpio et al., 2016 . We therefore employed this tool to interrogate the cellular heterogeneity within EpCAM + populations of human liver tissue to identify a true liver stem / progenitor cell.
Results

Enrichment for progenitor cells in human foetal liver
Previous studies identified putative human hepatic stem /progenitor cells to be within the EpCAM + /NCAM + population (Schmelzer et al., 2007) . We therefore decided to employ a cell sorting strategy to enrich for potential hLPCs and deplete contaminating blood cells. We obtained five separate freshly isolated human foetal liver samples during the second trimester of gestation. Cells were isolated as previously reported (Gramignoli et al., 2012 ) and sorted on cell surface markers CD235a (red blood cell marker), CD45 (leukocyte marker), (Supplementary table 1) . RNA from each cell was isolated and sequenced across four 384-multiplex libraries (along with adult single cell samples). In total (including adult cells, Figure   3A ) ~1400 cells were captured and sequenced. Post-alignment, raw counts were processed through the SCATER scRNA pipeline for quality control (qc) (McCarthy et al., 2017) . After Figure 1C ). Only clusters F1 and F2 were enriched for ALB expression, defining them to be hepatic (Doweiko and Nompleggi, 1991) ( Figure 1D ). The remaining clusters, F3, F4 and F5 were negative for ALB and HNF4a
suggesting the presence of non-hepatic cell types (Ballester et al., 2014) . Hepatoblast markers AFP and DLK1 (Tanaka et al., 2009, Kuhlmann and Peschke, 2006) were enriched in population F1. Population F2 expressed previously reported hepatic progenitor markers EpCAM, CD24, SOX9 and CD133 (Furuyama et al., 2011 , Yovchev et al., 2008 , but were negative for AFP.
Population F3 expressed markers of mesothelial cells such as UPK3B and PKHD1L1 (KanamoriKatayama et al., 2011) . Both populations F2 and F3 were enriched for the LPC marker KRT19 (Tarlow et al., 2014) . F3 also expressed the mesenchyme marker COL1A1 (Friedman, 1996) .
F4 expressed COL1A1 alongside other extracellular matrix (ECM) associated genes including DCN and BGN (Rashid et al., 2012) . F5 expressed exclusive markers of erythroid cells such as KLF1 and RHAG (Miller and Bieker, 1993) (Hu et al., 2013 ) ( Figure 1D ). This was unexpected given our rigorous FACS strategy to deplete erythroid cells, informed by previous literature (Schmelzer et al., 2006) . We therefore confirmed through flow cytometric analysis that the F5-specific marker TFRC was expressed on a sub-population of CD235a -and EpCAM + cells (Supplementary Figure 1D) , confirming that the F5 population was not a contaminate celltype. This suggests the possibility of erythroid-like cells existing within CD235a within cell populations previously identified to be hepatic stem/progenitor cells (Huch et al., 2015 , Schmelzer et al., 2007 ( Figure 1G ). (Terada, 2013) , a layer of cells surrounding the portal tract ( Figure 2A , Supplementary Figure 2A ). Protein expression was validated by immunohistochemistry (IHC) and immunofluorescence (IF). We confirmed these regions were positive for previously reported ductal plate and hepatic progenitor markers EpCAM and CK19
CDH6 defines a sub population of
and CLDN3 (Terada, 2013 , Schmelzer et al., 2006 , along with our newly identified markers CDH6 and STAT1 ( Figure 2B -C, Supplementary Figure 2B ). (Huch et al., 2015) ( Figure 2D ). After multiple passages, expanded organoids were positive for CDH6 as well as classical progenitor markers EpCAM, SOX9,
6
CLDN3, KRT7 and HNF4A ( Figure 2E-F) . Transferring organoids to a hepatic differentiation medium, could induce expression of albumin protein after 7 days, confirming the hepatic differentiation potential of CDH6 + organoids ( Figure 2G ). In comparison, organoids derived from foetal gall bladder were negative for CDH6, positive for biliary marker KRT7 ( Figure 2H ), and unable to generate albumin positive cells in modified hepatic differentiation conditions (Huch et al., 2013) . Taken (Schwartz et al., 1981) . This tissue was obtained from donor grafts, the remainder of which were successfully implanted into patients with liver failure ( Table   5 ). RNA-ISH confirmed CDH6 and STAT1 expression in both bile ducts and at the limiting plate, a layer of hepatic cells that borders the portal tract (Turner et al., 2011 , Paku et al., 2005 ( Figure 3G ). As we were unable to source further normal human adult liver tissues for prospective isolation of the CDH6 + population, we validated their presence in cells expanded from Endoscopic Retrograde Cholangio-Pancreatography (ERCP) brushings (Ferrari Júnior et al., 1994) . We confirmed CDH6 co-expression with the classical ductal / progenitor markers CLDN3, EpCAM and KRT7 in these primary adult samples ( Figure 3H ).
Combined foetal and adult hLPC scRNA-seq analysis identifies TROP-2 as a biliary lineage specification marker
Having confirmed the presence of a CDH6 + progenitor population both within foetal and adult human liver tissue, we went on to characterise its potential role in liver development. We first performed 2-D t-SNE distribution and Spearman's correlation on combined foetal and adult liver scRNA-seq data sets, confirming by K-means clustering that foetal hLPCs are transcriptionally closer to adult hLPCs than any other cell type ( Figures 4A-B) . Next, to characterise the relationship between foetal and adult hLPCs, we ordered the combined hLPC populations by pseudo-lineage using the R package monocle (Trapnell et al., 2014) , to predict the trajectory of hLPC fate. Populations were clustered by 'pseudo state' in 2-D space ( Figure   4C contained a small population of cells that diverged between pseudo state 1 and 2 ( Figure 4C ).
Gene expression analysis revealed significant transcriptional changes from pseudo states 1- 
Lineage specific markers correlate with hepatocellular carcinoma and intrahepatic cholangiocarcinoma transcriptional signatures
There is no clear consensus on the definition of a 'cancer stem cell' or 'tumour initiating cell' (Sia et al., 2017) . We hypothesized that specific transcriptional changes captured during hepatic and biliary lineage specification, may provide critical insight into the mechanisms of intra-hepatic cancer progression. Utilising a published integrated analysis of differentially 9 expressed genes in hepatocellular carcinoma (HCC) vs intrahepatic cholangiocarcinoma (ICC),
we observed a striking correlation with genes enriched during hepatic and biliary lineage specification. 3650 significantly upregulated genes were found in HCC vs ICC, while 3663 genes were significantly downregulated. We compared differentially regulated HCC vs ICC genes to our pseudo lineage bifurcation transcriptional changes ( Figure 5 Ai) (Xue et al., 2015) .
Of the 453 upregulated genes in hepatic progenitors (pseudo state 4) ( (Langfelder and Horvath, 2008) . As expected, the progenitor co-expression network contained EpCAM, CDH6 and STAT1, validating our scRNA-seq predictions of the true hLPC phenotype ( Figure 5F ). These results demonstrate the close correlation between hLPC fate specification with HCC and ICC gene signatures.
Identification of an hLPC-specific signature in cancer and chronic liver injury
Having identified a true hLPC population in normal tissue, and observed that lineage specification correlates with gene expression changes in HCC and ICC, we next investigated the distribution of cells with hLPC signatures in cancer and liver injury. In normal adult liver tissue, CDH6 expression is observed in bile ducts and at the limiting plate, whilst TROP-2 is restricted to bile ducts ( Figure 6A, Supplementary Figure 6 ). In HCC tissue with stem-cell like morphological dedifferentiation, CDH6 expression was observed, whilst TROP-2 was not.
However, cells in ICC were positive for both CDH6 and TROP-2 ( Figure 6B ). Neither CDH6, nor TROP-2, were found in conventional HCC samples. We next looked at CDH6 and TROP-2 expression within the context of liver injury and observed acute liver injury to be associated Figure 6 ). These findings demonstrate that the transcriptional profile of hLPCs identified in our study, have exciting applications in distinguishing between diagnostically challenging liver diseases.
Discussion
In this study, we have captured the molecular identities of three different types of hepatocyte -adult, hepatoblast and progenitor (hLPC) using scRNA-seq. hLPCs localize to the ductal plate of human foetal liver and are retained in its embryological remnant, the limiting plate, of normal adult liver. We identify new surface markers that define this population including CDH6 and FGFR2 along with transcription factors such as STAT1. These cells can be distinguished from cholangiocytes/biliary epithelial cells (BECs) that populate intra-hepatic bile ducts by negative expression of TROP-2. We go on to show that hLPCs may play a putative role within sub-types of chronic liver injury and intra-hepatic cancer.
The current literature has identified putative liver progenitor/stem-cell populations as EpCAM + cells residing in ductal regions or arising from biliary cell dedifferentiation upon injury (Schmelzer et al., 2007 , Tarlow et al., 2014 , Raven et al., 2017 . There is a lack of clarity as to whether the origin and identity of the true hLPC phenotype, compounded by the significant overlap in markers between progenitor/stem-cell populations and cholangiocytes/BECs.
Markers including EpCAM, CD24, CD133, CK7, CK19 and SOX9 have been previously associated with both progenitor and BECs in murine and human studies (Yovchev et al., 2007 , Mishra et al., 2009 . Furthermore, progenitor markers are commonly associated with liver cancer. It is thought these might help in defining the cellular origin of the tumour (progenitor, biliary or mature hepatocyte) and differentiate hepatocellular from cholangiocarcinoma (Suetsugu et al., 2006 , Roskams, 2006 , Sia et al., 2017 . Previous studies lack the single cell resolution necessary to accurately define the origin and identify of the true hLPC phenotype and its functional contribution to development, regeneration in response to injury and misregulation during disease. Our hLPCs, defined at a single cell resolution, on the other hand were positive for conventional markers (EpCAM, CD24, CD133, KRT7, KRT19 and SOX9) , new markers (CDH6, FGFR2, CTNND2, STAT1, MCAM, GPRC5B) but negative for more mature hepatoblast markers (AFP, CYP3A7 and DLK1) (Schwartz et al., 1981 , Rowe et al., 2013 . These hLPCs were found to reside in the foetal liver ductal plate, and maintained in the adult liver limiting plate. By pseudo-lineage analysis we identified a hLPC bifurcation map which identified TROP-2 as a marker of commitment towards the biliary lineage. We confirmed this using in situ RNA hybridization, and showed that a CDH6 + hLPC population located at the ductal plate, could be distinguished from cholangiocytes/BECS in bile ducts by the absence of TROP-2 expression.
The power of our experimental approach is highlighted by the finding of hLPC markers CDH6/STAT1 which also appear to be conserved in progenitors across multiple lineages.
( Shimazui et al., 2000 ) (Sagrinati et al., 2006 , Kim et al., 2011 , Lu et al., 2015 , Schmelzer et al., 2007 . This supports the idea of a core molecular programme responsible for maintenance of tissue resident stem/progenitor cells (Furuyama et al., 2011 , Watt, 2014 , Hishikawa et al., 2015 . Our data also highlight the important species-specific differences that exist, which likely have led to such confusion in the field. For example, TROP-2 a closely related family member of EpCAM, is thought to be absent in normal tissue and be expressed only at times of injury (Okabe et al., 2009) or cancer (Cubas et al., 2009 ). Our data clearly shows this is not the case in humans, with TROP-2 being overexpressed in cholangiocarcinoma but also found in bile ducts during normal homeostasis. This raises intriguing questions about the validity of using murine models for human disease research.
Our data provides new knowledge in the direct study of human developmental biology, by molecularly defining the lineage hierarchy from progenitor to adult cell via an intermediate hepatoblast stage (Schmelzer et al., 2007 , Schmelzer et al., 2006 , Turner et al., 2011 .
Uncovering the critical regulatory mechanisms driving hepatic maturation will provide an important road map to help unlock the challenges faced in converting pluripotent stem cells to clinically relevant hepatocytes (Baxter et al., 2015) . It will also offer new targets for direct 13 cell reprogramming strategies (Nakamori et al., 2017) . Finally, our analysis demonstrated remarkable similarity exists between hepatic and biliary progenitors and human HCC and ICC gene expression profiles respectively. This supports the idea that certain forms of cancer may involve reversion to or are driven by cancer stem/progenitor cells and so provides a clinically relevant transcriptional signature to potentially distinguish between diagnostically challenging intra-hepatic tumors.
In summary, we have identified and characterized a true progenitor cell population in human foetal liver, which is retained in normal adult liver and appears to be re-activated in certain types of injury. Further in-depth characterization of the mechanisms regulating the behaviour of this new cell type will afford significant advancement in our understanding of human liver development and disease.
Methods
ScRNA-Seq cell sorting and cDNA library preparation. at 1:1000 dilution was used for live/dead staining. Single-cell sequencing was performed using SmartSeq2 as described (Picelli et al., 2014) . Briefly, cells were sorted using a BD FACS Aria II instrument and deposited as single cells into 96-well plates, pre-loaded with lysis buffer (1% Triton X-100, 1mM dNTP, 1μM oligo-dT30 
DNA sequencing and analysis of Single-Cell Transcriptomes
Raw sequencing reads were aligned using STAR and per gene counts were calculated using HTSEQ (Dobin et al., 2013 , Anders et al., 2015 . Gene counts were further analyzed using the R package SCATER for pre-processing, quality control and normalization (McCarthy et al., 2017) . T-SNE, spearman's ranks co-efficient, hierarchical clustering, and Student's t tests were performed using custom scripts in R. T-SNE was performed on log10(TPM) normalized gene counts. User-defined K-means clustering was performed in R. Gene set enrichment analysis (GSEA) was performed on normalized scRNA-seq gene expression data through GSEA 15 software run using the KEGG pathway collection (Subramanian et al., 2005) . Pseudo lineage and trajectory analysis was performed in R using the monocle package (Trapnell et al., 2014) .
Gene co-expression networks were constructed using the blockwiseModules function in the WGCNA package of the R software (Langfelder and Horvath, 2008) . Networks were visualized in Cytoscape (Shannon et al., 2003) .
In Situ RNA Hybridization (RNA-ISH)
Freshly isolated foetal and adult human liver samples were fixed in 10% formalin buffer saline (HT501128, Sigma Aldrich) for two days then dehydrated and paraffin wax infiltrated using 
IHC -Tissue sections
Paraffin-embedded foetal liver tissue were prepared as described for RNA-ISH. After embedding, sections (5µm) were stained using mouse and rabbit specific HRP/AEC ( Acetylcysteine, 1% penicillin-streptomycin, 1% ITS and the growth factors: 50 ng/ml EGF, 500 ng/ml, RSPO1, 0.1 μM dexamethasone, 1:100 WNT3a and 10 µM Y27632. The culture medium was changed every 48 hours.
Passaging and staining organoids
To split f-IHOs and f-EHOs, Matrigel® was digested with Trypsin-EDTA for 15 minutes at 37 °C.
Cell suspension was centrifuged at 300g for 4 minutes, washed once with William's E medium and resuspended in Matrigel® domes as described above. Organoids were typically passaged F5   F3   F4   F1 F2  F3  F4  F5  F1 F2  F3  F4  F5  F1 F2  F3  F4  F5  F1 F2  F3  F4  F5  F1 F2  F3  F4 Schematic of human CDH6 and TROP-2 expression in normal, tumour and liver injury models.
